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Background/aim: To compare outcomes of canal wall up (CWU) and canal wall down (CWD) techniques in the treatment of middle
ear cholesteatoma.
Materials and methods: Medical records of 76 patients who had a primary surgery due to middle ear cholesteatoma between July 2015
and November 2017 were reviewed retrospectively. Hearing thresholds, speech discrimination scores (SDS), recurrences, and revision
surgeries of CWU and CWD surgeries were compared.
Results: Of 76 cholesteatoma cases, 40 (52.6%) had a CWU and 36 (47.4%) had a CWD operation. Postoperatively, the mean air
conduction thresholds were significantly better in CWU compared to CWD surgeries (P = 0.016). The presence of the stapes and the
type of reconstruction material used did not have a significant effect on auditory success rates (P = 0.342 and P = 0.905, respectively).
Auditory success was affected by the status of the middle ear mucosa as well. The recurrence and revision rates did not differ between
the surgical techniques (P > 0.05).
Conclusion: Status of the middle ear mucosa and external auditory canal are important factors affecting the outcomes in cholesteatoma.
Instead of a CWD surgery, a CWU surgery seems applicable in cases of cholesteatoma when the bone in the external auditory canal is
not eroded by the disease.
Key words: Cholesteatoma, mastoidectomy, tympanoplasty, ossicular replacement

1. Introduction
Cholesteatoma is a cystic lesion composed of keratinized
squamous epithelium [1].
Once diagnosed, surgical treatment is inevitable
because of its progressive destructive character and
potential to cause functional loss and severe complications
[2]. The aim of cholesteatoma surgery is to completely
eradicate the disease and to obtain satisfactory hearing.
Canal wall down (CWD) and canal wall up (CWU)
are the surgical techniques used in the treatment of
cholesteatoma. These techniques are mainly distinguished
by preservation of the external ear canal. CWD is
considered to be the more effective method for eradication
of cholesteatoma, as it allows the evaluation of mastoid and
middle ear structures with a wide angle of view. However,
a self-cleaning cavity cannot usually be obtained in the
CWD technique and the patient should avoid contact
with water, which will lead to social limitations. These
problems are avoided in the CWU technique because
the anatomy is preserved. However, residual disease and

recurrences may be more common in CWU than in CWD
[3]. In addition, hearing results with CWU are considered
to be better than with CWD [4–7].
After CWU surgeries, the inability to observe the cavity
directly during postoperative otoscopic examination is an
important handicap for the follow-up of cholesteatoma
recurrence. Hence, a second-look surgery for residual
disease monitoring is recommended [8].
Nonecho–planar
diffusion-weighted
magnetic
resonance imaging (non-EPI-DW MRI) is also favored
as an alternative method in postoperative cholesteatoma
screening after CWU surgeries [9,10].
Sinus tympani and facial recesses are the most
common localizations from which cholesteatoma
recurrence originates [11,12]. These areas are difficult to
visualize in the CWU technique through the ear canal
or the mastoid cavity. A posterior tympanotomy (PT)
provides direct access to the facial recesses and sinus
tympani and helps to eradicate cholesteatoma in the
CWU technique [13].
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The aim of this study was to compare hearing outcomes
and disease eradication rates for CWU and CWD
techniques in the treatment of middle ear cholesteatoma.
Improvements in hearing thresholds and speech
discrimination scores (SDS), rates of recurrence, and
revision surgeries were the main parameters compared
between CWU and CWD surgeries. Factors influencing
hearing outcomes and disease eradication were further
evaluated.
2. Materials and methods
Medical records of 76 patients who had a primary surgery
due to acquired middle ear cholesteatoma between July
2015 and November 2017 were reviewed retrospectively,
and the data related to preoperative and postoperative
hearing thresholds, speech discrimination scores (SDS),
surgical techniques, recurrences, and revision surgeries
were recorded after ethical committee approval was
obtained from the university. Informed consent was
obtained from all individual participants. There were
no patients with congenital, petrous bone, or revision
cholesteatoma.
The surgeries were performed under general anesthesia,
using a retroauricular approach. A CWD surgery was
performed in cases of erosion in the bone of the external
auditory canal. A CWU surgery was performed when
the bone in the external auditory canal was intact. The
CWU surgeries were performed with a PT (CWU+PT)
or without a PT (CWU–PT) depending upon accessibility
to the cholesteatoma matrix in the facial recess and sinus
tympani. In CWU, the incus and head of the malleus were
removed as needed, and the posterior buttress was removed
when a PT was performed. Surgeries were classified
according to the criteria determined by the International
Otology Outcome Group and the International Consensus
on the Categorization of Tympanomastoid Surgery, in
order to comply with the current nomenclature [14]. In
this context, CWU–PT, CWU+PT, and CWD surgeries
performed in this study match with M1a, M1b, and M2c
surgeries in the current nomenclature, respectively.
In the postoperative period, all patients were followed
up with periodic otoscopic examinations for recurrence.
Instead of a second-look surgery for recurrent or residual
cholesteatoma, the CWU cases (M1a and M1b) were
assessed with non-EPI-DW MRI at least 1 year after the
surgery.
Epitympanic cholesteatoma was accepted as recurrence
and cholesteatoma behind the mesotympanum was
encountered as residual disease, as suggested by Jackler
et al. [15]. The term recidivism was used to define both
recurrence and residual disease [3,16].
The hearing outcomes were reported in accordance with
the Committee on Hearing and Equilibrium Guidelines

of the American Academy of Otolaryngology - Head and
Neck Surgery, and comply with Level 1 guidelines [17]. A
scattergram was formed for the techniques as described in
the new standardized format of the guidelines [18]. The last
performed postoperative audiometry after the first year of
each case was obtained, and 10 dB gain in air conduction or
air-bone gap of 20 dB or less in postoperative audiometry
was accepted as an auditory success.
3. Results
The SPSS 20.0 software program (IBM Corp., Armonk,
NY, USA) was used for the statistical analyses. The Mann–
Whitney and chi-squared tests were used to compare
quantitative and ordinal variables, respectively. P-values
less than 0.05 were considered statistically significant.
There were 42 (55.3%) males and 34 (44.7%) females
with a mean age of 33.8 (min: 6, max: 61) years. The disease
was on the left side in 34 (44.7%) and on the right side in
42 (55.3%) patients. Mean follow-up time was 25.1 months
(min: 12, max: 54 months).
Of 76 cholesteatoma cases, 40 (52.6%) had a CWU
and 36 (47.4%) had a CWD operation. The demographic
features did not differ between these groups (P > 0.05).
In CWU operations, a PT was also performed (M1b) in
28 (36.8%), while a PT was not performed (M1a) in 12
(15.8%) patients.
Overall, preoperative and postoperative mean pure
tone air conduction thresholds were 45.9 dB and 40.03 dB,
respectively (P = 0.003). The mean air–bone gap changed
from 31.4 dB to 24.8 dB after the operation (P < 0.001).
Preoperative and postoperative mean SDS were 91.9% and
91.37%, respectively (P = 0.564).
Preoperatively, the mean pure tone air conduction
thresholds were 42.6 dB, 46.4 dB, and 46.7 dB in M1a,
M1b, and M2c groups, respectively, which were not
significantly different (P = 0.759). Postoperatively, the
mean air conduction thresholds were 34 dB, 34.25 dB,
and 46.53 dB in M1a, M1b, and M2c groups, respectively,
which was significantly better in CWU compared to CWD
surgeries (P = 0.016) (Figure 1).
Postoperatively, air–bone gap gains were 10.2 dB,
12.3 dB, and 0.8 dB in M1a, M1b, and M2c surgeries,
respectively, which was significantly better in CWU
compared to CWD surgeries (P = 0.006). There was no
significant difference between M1a and M1b surgeries in
terms of mean air–bone gap gains (P = 0.542) (Figure 2).
No statistical significance was found between the surgeries
regarding the changes in SDS (P = 0.417).
The stapes was intact in 45 (59%) cases. There was
stapes superstructure erosion requiring total ossicular
chain reconstruction in 31 (41%) patients. Otografts
(incus, malleus, or cortical bone) were used for ossicular
reconstruction in 56 (73.6%) patients. Hydroxyapatyte
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Figure 1. Scattergram diagrams of each surgical technique.

Figure 2. Comparison of ABG gains between surgical techniques.

total ossicular reconstruction prosthesis (TORP) and
partial ossicular reconstruction prosthesis (PORP) were
used in 12 (15.7%) and 4 (5.2%) patients, respectively. In
one (1.3%) patient, incudostapedial bridging was made
with bone cement, and the ossicular chain was left intact
in 3 (3.9%) patients. There was no statistically significant
difference between CWD and CWU surgeries by the
means of reconstruction material used (P = 0.483). The
gains in air–bone gap and SDS were not related with the
reconstruction material used (P = 0.999 and P = 0.819,
respectively) (Table 1). The presence of stapes did not
influence the gains in air–bone gap closure or SDS (P
> 0.05) (Table 2). Presence of the stapes and the type of
reconstruction material did not have a significant effect
on auditory success rates (P = 0.342 and P = 0.905,
respectively).
A hyperplastic middle ear mucosa with granulation
tissues was present in 57 (75%) of the patients. In 19
(25%) patients, the middle ear mucosa was normal in
appearance. The gains in air–bone gap closure and SDS
were significantly better in the presence of healthy middle
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Table 1. Auditory success and failure rates of each hearing
reconstruction technique.
Auditory success

Auditory fail

N

%

N

%

Autograft

34

60.7

22

39.3

TORP

7

58.3

5

41.7

PORP

3

75.0

1

25.0

Bone cement

1

100.0

0

0.0

N/A

2

66.7

1

33.3

ear mucosa (P = 0.015 and P = 0.01, respectively). Overall,
auditory success was achieved in 47 (61.8%) patients. The
rates of auditory success were 75% and 47.2% in CWU
and CWD surgeries, which were significantly higher in
the CWU group (75%) (P = 0.045). Auditory success was
affected by the status of the middle ear mucosa as well.
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Table 2. Comparison of hearing parameters according to presence of the stapes.

Pre-op PTA
Post-op PTA
Gain (dB)
Pre-op gap
Post-op gap
ABG gain
Pre-op SD
Post-op SD
SD gain

Stapes

N

Mean

Std. deviation

+

45

43.62

17.76

-

31

49.29

15.22

+

45

39.11

20.88

-

31

41.35

16.03

+

45

4.51

15.12

-

31

7.87

18.74

+

45

29.67

11.94

-

31

34.00

14.81

+

45

23.04

15.14

-

31

27.32

14.07

+

45

6.40

13.22

-

31

6.68

17.93

+

45

91.96

11.79

-

31

91.97

9.43

+

45

90.44

13.01

-

31

92.71

8.42

+

45

–1.56

7.91

-

31

0.74

7.74

Mean difference

*P-value

–5.67

0.152

–2.24

0.616

–3.36

0.391

–4.33

0.163

–4.28

0.217

–.28

0.938

–.01

0.996

–2.27

0.396

–2.30

0.213

*Independent samples test.
Table 3. Comparison of cholesteatoma recidivism between
surgical techniques.
Recidivisim

M1a
M1b
M2c
Total

Total

+

-

N

1

11

12

%

8.3

91.7

100.0

N

3

25

28

%

10.7

89.3

100.0

N

7

29

36

%

19.4

80.6

100.0

N

11

65

76

%

14.5

85.5

100.0

The rates of auditory success were 84.2% and 54.4% in the
presence of a normal and hyperplastic middle ear mucosa,
respectively (P = 0.028).
The rates of cholesteatoma recidivism which required
revision surgery were 8.3%, 10.7%, and 19.4% for M1a,
M1b, and M2c groups, respectively (Table 3). The cause
of recidivism was residual disease in all 7 M2c and 1 M1a

groups. In the M1b group, 1 of 3 recidivism cases was due
to a secondary retraction pocket formation; this case was
accepted as a recurrence. In the remaining 2 cases, the
residual disease was found behind the mesotympanum.
An additional 4 patients in the M1b group underwent
revision surgery due to retraction pocket development
without a cholesteatoma formation. Overall revision
surgery rates were 8.3%, 25%, and 19.4% for the M1a,
M1b, and M2c groups, respectively. The recurrence and
revision rates did not differ between the groups (P > 0.05).
In all cases of revision, the middle ear mucosa was found
out to be hyperplastic in the initial surgery. A revision
surgery was not required for any of the patients who had a
normal middle ear mucosa in the initial surgery. There was
a significant relationship between the status of the middle
ear mucosa and revision surgery (P = 0.016).
4. Discussion
The present study demonstrated better hearing outcomes and
similar recurrence rates for CWU surgeries when compared
with the CWD technique in cases of cholesteatoma when
the bone in the external auditory canal was not eroded
by the disease. The status of the middle ear mucosa and
external auditory canal was found to be the most important
factor affecting the outcomes in cholesteatoma surgery.
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The primary objective of cholesteatoma surgery is to
eradicate squamous epithelium from the middle ear and
mastoid cavity. However, maintaining satisfactory hearing
and prevention of recurrences are also important.
CWD techniques are favored because of the better
visualization of the middle ear status compared to CWU
techniques [19]. Better visualization allows for complete
eradication of the disease from the middle ear. The vast
majority of the studies in the literature report a lower
recurrence rate in CWD surgeries when compared with
the CWU technique [3,20–22] By contrast, in the present
series, cholesteatoma recurrence and revision surgery rates
were similar between the CWD and CWU techniques.
However, the relatively short follow-up duration (around
2 years) might have an impact on that similarity, because a
5-year follow-up is advised to make an accurate recurrence
evaluation [3].
The traditional follow-up method for residual or
recurrent cholesteatoma after CWU surgeries is a secondlook operation [8]. However, non-EPI–DW MRI has
emerged within the last decade as a noninvasive, less
time-consuming, and cost-effective alternative to secondlook operations in postoperative cholesteatoma screening
after CWU surgeries. Cholesteatomas show distinct
signals in non-EPI–DW MRI and are distinguished from
postoperative mucosal changes successfully [9,10]. De
Foer et al. showed high sensitivity, specificity, and positive
and negative predictive values with non-EPI–DW MRI in
residual cholesteatoma screening after CWU surgeries.
They claimed non-EPI–DW MRI is capable of detecting
even very small cholesteatomas and has the ability to select
appropriate candidates for second-look surgery, avoiding
unnecessary surgery [9]. In the present series, we also
used non-EPI–DW MRI for cholesteatoma screening after
CWU surgeries. None of the patients in which a highsignal intensity lesion was not present in non-EPI–DW
MRI has undergone a revision surgery.
In general, extension or severity of the disease can
affect the preference of surgical technique in cases of
cholesteatoma. In addition, status of the middle ear mucosa
is an important factor affecting postoperative outcomes
[23–25]. The present study also supports this contention
since the mucosal status significantly correlated with
revisions, recurrences, and hearing outcomes, regardless
of the surgical technique applied.

Ossiculoplasty is critical in hearing restoration.
In CWU surgeries, PT is considered to help visualize
the position of ossiculoplasty material. However, that
maneuver usually does not affect hearing outcomes
[26]. In our study, although the best hearing outcome
could be achieved with the M1b technique, there was no
statistically significant difference between M1a and M1b
surgeries. The hearing results of CWU surgeries were
better than those of CWD surgeries. These results suggest
that hearing results are related to preservation of the
external auditory canal.
Stapes superstructure is considered to play an
important role in hearing restoration, and better hearing
results with PORP compared to TORP have been reported
by some authors [5,27,28], while other authors did not
find a significant effect of the stapes superstructure on
postoperative hearing outcome [25,29,30]. In the present
study, the presence of the stapes superstructure did not
influence hearing outcomes. We think that a well-aerated
middle ear cleft with a healthy mucosal lining is essential
for good postoperative hearing. A small middle ear cleft
due to CWD surgery and presence of mucosal disease
which impairs normal middle ear functions may prevent
efficient ossicular chain movement and cause poor hearing
outcomes in patients with an intact stapes superstructure,
even if the ossicular chain is completely intact as seen in
some adhesive otitis media cases.
There are controversies about the effects of the
ossicular reconstruction materials on hearing outcomes,
because similar hearing outcomes have been reported
with different reconstruction materials [28,31,32]. By
contrast, better hearing outcomes were also reported with
autograft PORP compared to allograft reconstruction
materials [33]. Another study reported better outcomes
with titanium TORP when compared with the autologous
incus [34]. In our study, no statistically significant
difference could be found between the ossicular chain
reconstruction materials in relation to hearing outcomes.
In conclusion, status of the middle ear mucosa and
external auditory canal are important factors affecting the
outcomes in cholesteatoma. Instead of a CWD surgery, a
CWU surgery seems applicable in cases of cholesteatoma
when the bone in the external auditory canal is not eroded
by the disease.
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